These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1261 related articles for article (PubMed ID: 9480612)

  • 21. Ultrasound and amniotic fluid alpha-fetoprotein in the prenatal diagnosis of spina bifida.
    Allen LC; Doran TA; Miskin M; Rudd NL; Benzie RJ; Sheffield LJ
    Obstet Gynecol; 1982 Aug; 60(2):169-73. PubMed ID: 6185890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of need for amniocentesis in patients with elevated levels of maternal serum alpha-fetoprotein and normal ultrasonographic examinations.
    Nadel AS; Green JK; Holmes LB; Frigoletto FD; Benacerraf BR
    N Engl J Med; 1990 Aug; 323(9):557-61. PubMed ID: 1696358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risks associated with an elevated amniotic fluid alpha-fetoprotein level.
    Crandall BF; Matsumoto M
    Am J Med Genet; 1991 Apr; 39(1):64-7. PubMed ID: 1714237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of amniotic fluid alpha-fetoprotein and acetylcholinesterase in the prenatal diagnosis of open neural tube defects and anterior abdominal wall defects.
    Loft AG; Høgdall E; Larsen SO; Nørgaard-Pedersen B
    Prenat Diagn; 1993 Feb; 13(2):93-109. PubMed ID: 7681980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal diagnosis of open neural tube defects using the amniotic fluid acetylcholinesterase assay.
    Milunsky A; Sapirstein VS
    Obstet Gynecol; 1982 Jan; 59(1):1-5. PubMed ID: 6176922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Routine measurement of amniotic fluid alpha-fetoprotein and acetylcholinesterase: the need for a reevaluation.
    Flick A; Krakow D; Martirosian A; Silverman N; Platt LD
    Am J Obstet Gynecol; 2014 Aug; 211(2):139.e1-6. PubMed ID: 24530818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abdominal wall defects and congenital heart disease.
    Gibbin C; Touch S; Broth RE; Berghella V
    Ultrasound Obstet Gynecol; 2003 Apr; 21(4):334-7. PubMed ID: 12704739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Discolored amniotic fluid--results of prenatal diagnosis and clinical significance].
    Gnirs J; Boos R; Hendrik J; Hentemann M; Schmidt W
    Geburtshilfe Frauenheilkd; 1991 Mar; 51(3):217-22. PubMed ID: 1711490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
    Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
    Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
    Wenstrom KD; Owen J; Davis RO; Brumfield CG
    Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Assessment of AFP in amniotic fluid: comparison of three automated techniques].
    Leguy MC; Tavares Sdos R; Tsatsaris V; Lewin F; Clauser E; Guibourdenche J
    Ann Biol Clin (Paris); 2011; 69(4):441-6. PubMed ID: 21896409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
    J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-trimester screening for neural tube defects using alpha-fetoprotein.
    Bredaki FE; Poon LC; Birdir C; Escalante D; Nicolaides KH
    Fetal Diagn Ther; 2012; 31(2):109-14. PubMed ID: 22377693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Alpha fetoprotein concentration in the amniotic fluid in normal pregnancy and in pregnancy complicated by fetal anomaly].
    Szabó M; Veress L; Münnich A; Papp Z
    Orv Hetil; 1990 Sep; 131(39):2139-42. PubMed ID: 1699194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antenatal diagnosis of neural tube defects in Canada: extension of a collaborative study.
    Simpson NE; Dallaire L; Miller JR; Siminovitch L; Miller J; Hamerton JL
    Can Med Assoc J; 1979 Mar; 120(6):653-7. PubMed ID: 86382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are routine alpha-fetoprotein and acetylcholinesterase determinations still necessary at second-trimester amniocentesis? Impact of high-resolution ultrasonography.
    Sepulveda W; Donaldson A; Johnson RD; Davies G; Fisk NM
    Obstet Gynecol; 1995 Jan; 85(1):107-12. PubMed ID: 7528368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Amniotic fluid acetylcholinesterase and prenatal diagnosis of neural tube defects. II. Qualitative test].
    Guibaud S; Simplot A; Bonnet M; Thoulon JM; Guibaud P; Robert JM
    J Genet Hum; 1982 Jun; 30(2):119-34. PubMed ID: 7130961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal diagnosis, fetal surgery, recurrence risk and differential diagnosis of neural tube defects.
    Chen CP
    Taiwan J Obstet Gynecol; 2008 Sep; 47(3):283-90. PubMed ID: 18935990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prenatal diagnosis. Review, personal and prospective studies].
    Engel E; Empson J; DeLozier D; McGee B; da Costa Woodson E; Engel-de Montmollin M; Carter T; Lorber C; Cassidy SB; Millis J; Heller RM; Boehm F; Vanhooydonk J
    Schweiz Med Wochenschr; 1979 Jul; 109(27):998-1010. PubMed ID: 88763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ventral abdominal wall defects--antenatal diagnosis, course of pregnancy and post partum therapy].
    Rabe D; Hendrik HJ; Leucht W; Roth H; Walter C; Schmidt W
    Geburtshilfe Frauenheilkd; 1985 Mar; 45(3):176-82. PubMed ID: 3157611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.